Submitted:
25 June 2026
Posted:
29 June 2026
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Historical Evolution of Acid–Base Interpretation
3. The Traditional Buffer–Base Interpretation
4. The Stewart Physicochemical Approach
- Partial pressure of carbon dioxide (pCO₂)
- Strong ion difference (SID)
- Total concentration of weak acids (Atot)
- increased Atot (weak acid effect);
- altered SID due to accompanying chloride load.
5. Traditional Versus Stewart Interpretations
6. Physicochemical Simulations of Albumin Administration
7. Fluid Composition, Chloride Burden, and Strong Ion Difference
9. Masked Acidosis and Bedside Interpretation Pitfalls
10. Integrated Bedside Interpretation
11. Cardiorespiratory Interactions During Albumin Administration and Acid–Base Resuscitation
12. Randomized Controlled Trials: Clinical Context for Albumin and Fluid Composition
13. Future Directions
14. Limitations
15. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| AG | Anion gap |
| AKI | Acute kidney injury |
| Atot | Total concentration of weak acids |
| BE | Base excess |
| ICU | Intensive care unit |
| SID | Strong ion difference |
| SIG | Strong ion gap |
References
- Prescott, H.C.; Antonelli, M.; Alhazzani, W.; Møller, M.H.; Alshamsi, F.; Azevedo, L.C.P.; Belley-Cote, E.; De Waele, J.; Derde, L.; Dionne, J.C.; et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit. Care Med. 2026, 54(4), 725–812. [Google Scholar] [CrossRef] [PubMed]
- Meyhoff, T.S.; Hjortrup, P.B.; Wetterslev, J.; Sivapalan, P.; Laake, J.H.; Cronhjort, M.; Jakob, S.M.; Cecconi, M.; Nalos, M.; Ostermann, M.; et al. Restriction of Intravenous Fluid in ICU Patients with Septic Shock. N Engl. J. Med. 2022, 386(26), 2459–2470. [Google Scholar] [CrossRef] [PubMed]
- National Heart; Lung; and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network; Shapiro, N.I.; Douglas, I.S.; Brower, R.G.; Brown, S.M.; Exline, M.C.; Ginde, A.A.; Gong, M.N.; Grissom, C.K.; Hayden, D.; et al. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. N Engl. J. Med. 2023, 388(6), 499–510. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Finfer, S.; Bellomo, R.; Boyce, N.; French, J.; Myburgh, J.; Norton, R. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl. J. Med. 2004, 350(22), 2247–56. [Google Scholar] [CrossRef] [PubMed]
- Caironi, P.; Tognoni, G.; Masson, S.; Fumagalli, R.; Pesenti, A.; Romero, M.; Fanizza, C.; Caspani, L.; Faenza, S.; Grasselli, G.; et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl. J. Med. 2014, 370(15), 1412–21. [Google Scholar] [CrossRef] [PubMed]
- Sakr, Y.; Nierhaus, A.; Schumacher, U.; Utzolino, S.; Jaschinski, U.; Petros, S.; Fichtner, F.; Eimer, C.; Putensen, C.; Tanev, I.; et al. Albumin Replacement Therapy in Septic Shock: A Randomized Clinical Trial. JAMA Netw. Open 2026, 9(2), e2559297. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Vincent, J.L.; De Backer, D.; Wiedermann, C.J. Fluid management in sepsis: The potential beneficial effects of albumin. J. Crit. Care 2016, 35, 161–7. [Google Scholar] [CrossRef] [PubMed]
- Quinlan, G.J.; Martin, G.S.; Evans, T.W. Albumin: biochemical properties and therapeutic potential. Hepatology 2005, 41(6), 1211–9. [Google Scholar] [CrossRef] [PubMed]
- Caironi, P.; Gattinoni, L. The clinical use of albumin: the point of view of a specialist in intensive care. Blood Transfus. 2009, 7(4), 259–67. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Henderson, L.J. The theory of neutrality regulation in the animal organism. Am. J. Physiol.-Leg. Content 1908, 21:4, 427–448. [Google Scholar] [CrossRef]
- Hasselbalch, K.A. Die Berechnung der Wasserstoffzahl des Blutes aus der freien und gebundenen Kohlensäure desselben, und die Sauerstoffbindung des Blutes als Funktion der Wasserstoffzahl. In Julius Springer; 1916. [Google Scholar]
- Van Slyke, D.D. Acidosis and Alkalosis. Bull. N Y Acad. Med. 1934, 10(3), 103–37. [Google Scholar] [PubMed] [PubMed Central]
- Siggaard-Andersen, O. The Acid-base Status of the Blood. In Scandinavian journal of clinical and laboratory investigation: Supplementum, Suppl; Williams & Wilkins Company, 1964; Vol 70, ISSN 0085-591X. [Google Scholar]
- Astrup, P.; Jorgensen, K.; Andersen, O.S.; Engel, K. The acid-base metabolism. A new approach. Lancet 1960, 1(7133), 1035–9. [Google Scholar] [CrossRef] [PubMed]
- Schwartz, W.B.; Cohen, J.J. The nature of the renal response to chronic disorders of acid-base equilibrium. Am. J. Med. 1978, 64(3), 417–28. [Google Scholar] [CrossRef] [PubMed]
- Stewart, P.A. Modern Quantitative Acid-Base Chemistry. Can. J. Physiol. Pharmacol. 1983, 61, 1444–1461. [Google Scholar] [CrossRef] [PubMed]
- Fencl, V.; Jabor, A.; Kazda, A.; Figge, J. Diagnosis of metabolic acid-base disturbances in critically ill patients. Am. J. Respir. Crit. Care Med. 2000, 162(6), 2246–51. [Google Scholar] [CrossRef] [PubMed]
- Figge, J.; Rossing, T. H.; Fencl, V. The Role of Serum Proteins in Acid-Based Equilibria. J. Lab. Clin. Med. 1991, 117(6), 453–467. [Google Scholar] [PubMed]
- Figge, J.; Jabor, A.; Kazda, A.; Fencl, V. Anion gap and hypoalbuminemia. Crit. Care Med. 1998, 26(11), 1807–10. [Google Scholar] [CrossRef] [PubMed]
- Handy, J.M.; Soni, N. Physiological effects of hyperchloraemia and acidosis. Br. J. Anaesth. 2008, 101(2), 141–50. [Google Scholar] [CrossRef] [PubMed]
- Kraut, J.A.; Madias, N.E. Serum anion gap: its uses and limitations in clinical medicine. Clin. J. Am. Soc. Nephrol. 2007, 2(1), 162–74. [Google Scholar] [CrossRef] [PubMed]
- Feldman, M.; Soni, N.; Dickson, B. Influence of hypoalbuminemia or hyperalbuminemia on the serum anion gap. J. Lab Clin. Med. 2005, 146(6), 317–20. [Google Scholar] [CrossRef] [PubMed]
- Kellum, J.A. Closing the gap on unmeasured anions. Crit. Care 2003, 7(3), 219–20. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ystgaard, O.A. Hypoalbuminemi som årsak til metabolsk alkalose [Hypoalbuminemia as a cause of metabolic alkalosis]; Tidsskr Nor Laegeforen: Norwegian, 20 Aug 1982; Volume 102, 23, pp. 1151–2. [Google Scholar] [PubMed]
- Kellum, J.A. Clinical review: reunification of acid-base physiology. Crit. Care 2005, 9(5), 500–7. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Morgan, H.G. Acid-base balance in blood. Br. J. Anaesth. 1969, 41(3), 196–212. [Google Scholar] [CrossRef] [PubMed]
- Gilfix, B.M.; Bique, M.; Magder, S. A physical chemical approach to the analysis of acid-base balance in the clinical setting. J. Crit. Care 1993, 8(4), 187–97. [Google Scholar] [CrossRef] [PubMed]
- Corey, H.E. Bench-to-bedside review: Fundamental principles of acid-base physiology. Crit. Care 2005, 9(2), 184–92. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Yunos, N.M.; Bellomo, R.; Hegarty, C.; Story, D.; Ho, L.; Bailey, M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012, 308(15), 1566–72. [Google Scholar] [CrossRef] [PubMed]
- Young, P.; Bailey, M.; Beasley, R.; Henderson, S.; Mackle, D.; McArthur, C.; McGuinness, S.; Mehrtens, J.; Myburgh, J.; Psirides, A.; Reddy, S.; Bellomo, R.; SPLIT Investigators; ANZICS, C.T.G. Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial. JAMA Erratum in: JAMA. 2015 Dec 15;314(23):2570. doi: 10.1001/jama.2015.15495. PMID: 26444692. 2015, 314(16), 1701–10. [Google Scholar] [CrossRef] [PubMed]
- Semler, M.W.; Self, W.H.; Wanderer, J.P.; Ehrenfeld, J.M.; Wang, L.; Byrne, D.W.; Stollings, J.L.; Kumar, A.B.; Hughes, C.G.; Hernandez, A.; Guillamondegui, O.D.; May, A.K.; Weavind, L.; Casey, J.D.; Siew, E.D.; Shaw, A.D.; Bernard, G.R.; Rice, T.W. SMART Investigators and the Pragmatic Critical Care Research Group. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl. J. Med. 2018, 378(9), 829–839. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Self, W.H.; Semler, M.W.; Wanderer, J.P.; Wang, L.; Byrne, D.W.; Collins, S.P.; Slovis, C.M.; Lindsell, C.J.; Ehrenfeld, J.M.; Siew, E.D.; Shaw, A.D.; Bernard, G.R.; Rice, T.W.; SALT-ED Investigators. Balanced Crystalloids versus Saline in Noncritically Ill Adults. N Engl. J. Med. 2018, 378(9), 819–828. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Zampieri, F.G.; Machado, F.R.; Biondi, R.S.; Freitas, F.G.R.; Veiga, V.C.; Figueiredo, R.C.; Lovato, W.J.; Amêndola, C.P.; Serpa-Neto, A.; Paranhos, J.L.R.; Guedes, M.A.V.; Lúcio, E.A.; Oliveira-Júnior, L.C.; Lisboa, T.C.; Lacerda, F.H.; Maia, I.S.; Grion, C.M.C.; Assunção, M.S.C.; Manoel, A.L.O.; Silva-Junior, J.M.; Duarte, P.; Soares, R.M.; Miranda, T.A.; de Lima, L.M.; Gurgel, R.M.; Paisani, D.M.; Corrêa, T.D.; Azevedo, L.C.P.; Kellum, J.A.; Damiani, L.P.; Brandão da Silva, N.; Cavalcanti, A.B. BaSICS investigators and the BRICNet members. Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial. JAMA Epub ahead of print. 2021, 326(9), 1–12. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Finfer, S.; Micallef, S.; Hammond, N.; Navarra, L.; Bellomo, R.; Billot, L.; Delaney, A.; Gallagher, M.; Gattas, D.; Li, Q.; Mackle, D.; Mysore, J.; Saxena, M.; Taylor, C.; Young, P.; Myburgh, J. PLUS Study Investigators and the Australian New Zealand Intensive Care Society Clinical Trials Group. Balanced Multielectrolyte Solution versus Saline in Critically Ill Adults. N Engl. J. Med. 2022, 386(9), 815–826. [Google Scholar] [CrossRef] [PubMed]
- Wilcox, C.S. Regulation of renal blood flow by plasma chloride. J. Clin. Invest. 1983, 71(3), 726–35. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Hatherill, M.; Waggie, Z.; Purves, L.; Reynolds, L.; Argent, A. Correction of the anion gap for albumin in order to detect occult tissue anions in shock. Arch. Dis. Child 2002, 87(6), 526–9. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Pompili, E.; Zaccherini, G.; Baldassarre, M.; Iannone, G.; Caraceni, P. Albumin administration in internal medicine: A journey between effectiveness and futility. Eur. J. Intern Med. 2023, 117, 28–37. [Google Scholar] [CrossRef] [PubMed]
- Williams, J.M.; Greenslade, J.H.; Hills, A.Z.; Ray, M.T. Intervention With Concentrated Albumin for Undifferentiated Sepsis in the Emergency Department (ICARUS-ED): A Pilot Randomized Controlled Trial. Ann. Emerg. Med. 2025, 86(1), 59–69. [Google Scholar] [CrossRef] [PubMed]
- Magder, S.; Emami, A. Practical approach to physical-chemical acid-base management. Stewart at the bedside. Ann. Am. Thorac. Soc. 2015, 12(1), 111–7. [Google Scholar] [CrossRef] [PubMed]
- Bihari, S.; Bannard-Smith, J.; Bellomo, R. Albumin as a drug: its biological effects beyond volume expansion. Crit. Care Resusc. 2020, 22(3), 257–265. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- van de Wouw, J.; Joles, J.A. Albumin is an interface between blood plasma and cell membrane, and not just a sponge. Clin. Kidney J. 2021, 15(4), 624–634. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Pippalapalli, J.; Lumb, A.B. The respiratory system and acid-base disorders. BJA Educ. 2023, 23(6), 221–228. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Ijland, M.M.; Heunks, L.M.; van der Hoeven, J.G. Bench-to-bedside review: hypercapnic acidosis in lung injury--from 'permissive' to 'therapeutic'. Crit. Care 2010, 14(6), 237. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Magder, S. Bench-to-bedside review: ventilatory abnormalities in sepsis. Crit. Care 2009, 13(1), 202. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Lee, T.H.; Kuo, G.; Chang, C.H.; Huang, Y.T.; Yen, C.L.; Lee, C.C.; Fan, P.C.; Chen, J.J. Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis. PLoS ONE 2021, 16(12), e0260312. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Roch, A.; Guervilly, C.; Papazian, L. Fluid management in acute lung injury and ards. Ann. Intensive Care 2011, 1(1), 16. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Price, L.C.; Wort, S.J.; Finney, S.J.; Marino, P.S.; Brett, S.J. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review. Crit. Care 2010, 14(5), R169. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Kuper, M.; Gunning, M.P.; Halder, S.; Soni, N. The short-term effect of hyperoncotic albumin, given alone or with furosemide, on oxygenation in sepsis-induced acute respiratory distress syndrome. Anaesthesia 2007, 62(3), 259–63. [Google Scholar] [CrossRef] [PubMed]
- Mendes, R.S.; Pelosi, P.; Schultz, M.J.; Rocco, P.R.M.; Silva, P.L. Fluids in ARDS: more pros than cons. Intensive Care Med. Exp. 2020, 8 (Suppl 1), 32. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Annane, D.; Siami, S.; Jaber, S.; Martin, C.; Elatrous, S.; Declère, A.D.; Preiser, J.C.; Outin, H.; Troché, G.; Charpentier, C.; Trouillet, J.L.; Kimmoun, A.; Forceville, X.; Darmon, M.; Lesur, O.; Reignier, J.; Abroug, F.; Berger, P.; Clec'h, C.; Cousson, J.; Thibault, L.; Chevret, S.; CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA Erratum in: JAMA. 2013 Mar 12;311(10):1071. Régnier, Jean [corrected to Reignier, Jean]; Cle'h, Christophe [corrected to Clec'h, Christophe]. PMID: 24108515. 2013, 310(17), 1809–17. [Google Scholar] [CrossRef] [PubMed]





| Feature | Traditional approach | Stewart approach |
|---|---|---|
| Main determinant of pH | HCO₃⁻ / pCO₂ ratio | SID, Atot, pCO₂ |
| Role of albumin | Non-bicarbonate buffer | Weak non-volatile acid |
| Key variables | HCO₃⁻, BE, AG | SID, Atot, SIG |
| Hypoalbuminemia | Reduced buffering; lower measured AG | ↓ Atot → alkalinizing tendency |
| Albumin administration | Restores buffer base; may reduce BE | ↑ Atot → acidifying tendency |
| Saline acidosis | Hyperchloremic/dilutional acidosis | ↓ SID acidosis |
| Clinical strength | Simplicity and bedside familiarity | Mechanistic explanation of mixed disorders |
| Main limitation | Limited mechanistic resolution in complex ICU states | Less intuitive and more calculation-dependent |
| Fluid | Approximate SID | Chloride load | Atot effect | Expected net pH effect |
|---|---|---|---|---|
| Normal saline | 0 | High | None | Acidifying |
| Lactated Ringer | ~28 | Moderate | None | Neutral/slightly alkalinizing |
| Albumin 4% | ~0 | Moderate-high | Mild ↑ Atot | Mild acidifying |
| Albumin 20% | ~0 | High | Strong ↑ Atot | Acidifying |
| Scenario | Traditional interpretation | Stewart interpretation |
|---|---|---|
| Hypoalbuminemia + high lactate | Mild metabolic acidosis | Masked acidosis |
| Albumin infusion + ↓pH | Worsening metabolic acidosis | Restoration of Atot |
| Hyperchloremia | Hyperchloremic acidosis | ↓ SID acidosis |
| Near-normal BE with low albumin | Mild derangement | Hidden metabolic abnormality |
| Variable | Physiological meaning |
|---|---|
| pH | Overall acidemia/alkalemia |
| HCO₃⁻ | Metabolic component |
| Base excess | Buffer balance |
| Lactate | Tissue hypoperfusion, impaired clearance, or altered cellular metabolism |
| Chloride | SID effect |
| Albumin | Atot |
| Corrected anion gap | Hidden anions |
| SID | Physicochemical balance |
| Trial | Year | Sample size | Population | Intervention | Comparator | Main clinical finding | Relevance to this review |
|---|---|---|---|---|---|---|---|
| SAFE | 2004 | 6997 | General ICU patients requiring fluid resuscitation | 4% albumin | Normal saline | Similar 28-day outcomes in the overall population | Largest albumin–saline comparison; acid–base physiology not primary endpoint |
| ALBIOS | 2014 | 1818 | Severe sepsis/septic shock | 20% albumin plus crystalloids targeting serum albumin ≥30 g/L | Crystalloids alone | No reduction in 28-day or 90-day mortality overall | Most relevant sepsis trial; useful context for hyperoncotic albumin |
| CRISTAL | 2013 | 2857 | ICU patients with hypovolemic shock | Colloids, including albumin | Crystalloids | No significant difference in 28-day mortality | Contextual colloid evidence; not albumin-specific |
| ARISS | 2026 | 440 | Septic shock | Albumin replacement targeting serum albumin levels | Standard fluid therapy | Albumin administration appeared safe but did not improve 90-day survival | Modern septic-shock albumin trial; acid–base endpoints not primary |
| Trial | Year | Sample size | Population | Intervention | Comparator | Main clinical finding | Relevance to acid–base physiology |
|---|---|---|---|---|---|---|---|
| SPLIT | 2015 | 2278 | ICU patients | Plasma-Lyte 148 | Normal saline | No significant difference in AKI | Demonstrated modest chloride differences in low-volume ICU resuscitation |
| SMART | 2018 | 15,802 | Critically ill adults | Balanced crystalloids | Normal saline | Lower incidence of major adverse kidney events with balanced crystalloids | Landmark trial supporting chloride/SID relevance |
| SALT-ED | 2018 | 13,347 | Non-ICU adults treated in ED | Balanced crystalloids | Normal saline | Lower major adverse kidney events with balanced crystalloids | Extended balanced fluid findings beyond ICU |
| BaSICS | 2021 | 10,520 | Critically ill adults | Plasma-Lyte 148 | Normal saline | No overall mortality difference | Suggested physiological differences may not translate into major survival effects |
| PLUS | 2022 | 5037 | ICU patients | Plasma-Lyte 148 | Normal saline | No significant difference in AKI or mortality | Large modern ICU trial contextualizing chloride-related physiology |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).